Endocytosis and Transcytosis of Gliadin Peptides

Overview

Journal Mol Cell Pediatr

Publisher Springer

Specialty Pediatrics

Date 2016 Feb 18

PMID 26883352

Citations 20

Authors

M Vittoria Barone

K Peter Zimmer

Affiliations

Soon will be listed here.

Abstract

Background: Celiac disease (CD) is a frequent inflammatory intestinal disease, with a genetic background, caused by gliadin-containing food. Some gliadin peptides are not digested by intestinal proteases and can have different biological effects. Gliadin peptides can induce innate and adaptive T cell-mediated immune responses. The major mediator of the stress and innate immune response to gliadin peptides (i.e., peptides 31-43 and 31-55) is the cytokine interleukin-15 (IL-15). Other peptides such as the 33 mer containing the P57-68 sequence, after tissue transglutaminase deamidation, are well presented to T cell in the intestine and can induce an adaptive immune response.

Findings: In this paper, we review the recent studies on the digestion of gliadin and the peptides released by the digestion process. We will also discuss the mechanisms responsible for the internalization and transcytosis of indigested gliadin peptides in the intestinal epithelium.

Conclusions: Gliadin is not completely digested by the intestinal proteases producing bioactive peptides that have different biological effects. These peptides are internalized in the cells by an active process of endocytosis and can traverse the intestinal mucosa with different kinetics and immunological effects. In vivo findings will also be discussed.

Citing Articles

The Role of Gluten in the Development of Autoimmune Thyroid Diseases: A Narrative Review.

Esfahani K, Asri N, Mahmoudi Ghehsareh M, Rezaei-Tavirani M, Jahani-Sherafat S, Rostami-Nejad M Int J Endocrinol Metab. 2025; 22(3):e153730.

PMID: 40065831 PMC: 11892518. DOI: 10.5812/ijem-153730.

Translation of cell therapies to treat autoimmune disorders.

Mehta J, Hiremath S, Chilimba C, Ghasemi A, Weaver J Adv Drug Deliv Rev. 2023; 205:115161.

PMID: 38142739 PMC: 10843859. DOI: 10.1016/j.addr.2023.115161.

Quality and Agronomic Trait Analyses of Pyramids Composed of Wheat Genes , and .

Bu Z, Fang G, Yu H, Kong D, Huo Y, Ma X Int J Mol Sci. 2023; 24(11).

PMID: 37298204 PMC: 10252852. DOI: 10.3390/ijms24119253.

Why are western diet and western lifestyle pro-inflammatory risk factors of celiac disease?.

Skoracka K, Hryhorowicz S, Rychter A, Ratajczak A, Szymczak-Tomczak A, Zawada A Front Nutr. 2023; 9:1054089.

PMID: 36742009 PMC: 9895111. DOI: 10.3389/fnut.2022.1054089.

Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.

Wagh S, Lammers K, Padul M, Rodriguez-Herrera A, Dodero V Int J Mol Sci. 2022; 23(19).

PMID: 36233048 PMC: 9569549. DOI: 10.3390/ijms231911748.

References

Lebreton C, Menard S, Abed J, Moura I, Coppo R, Dugave C . Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology. 2012; 143(3):698-707.e4. DOI: 10.1053/j.gastro.2012.05.051. View

Sollid L . Molecular basis of celiac disease. Annu Rev Immunol. 2000; 18:53-81. DOI: 10.1146/annurev.immunol.18.1.53. View

Sarno M, Lania G, Cuomo M, Nigro F, Passannanti F, Budelli A . Lactobacillus paracasei CBA L74 interferes with gliadin peptides entrance in Caco-2 cells. Int J Food Sci Nutr. 2014; 65(8):953-9. DOI: 10.3109/09637486.2014.940283. View

Luciani A, Villella V, Vasaturo A, Giardino I, Pettoello-Mantovani M, Guido S . Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut. 2009; 59(3):311-9. DOI: 10.1136/gut.2009.183608. View

Mazumdar K, Alvarez X, Borda J, Dufour J, Martin E, Bethune M . Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques. PLoS One. 2010; 5(4):e10228. PMC: 2856682. DOI: 10.1371/journal.pone.0010228. View

Zimmermann C, Rudloff S, Lochnit G, Arampatzi S, Maison W, Zimmer K . Epithelial transport of immunogenic and toxic gliadin peptides in vitro. PLoS One. 2014; 9(11):e113932. PMC: 4240668. DOI: 10.1371/journal.pone.0113932. View

Mamone G, Nitride C, Picariello G, Addeo F, Ferranti P, Mackie A . Tracking the fate of pasta (T. Durum semolina) immunogenic proteins by in vitro simulated digestion. J Agric Food Chem. 2015; 63(10):2660-7. DOI: 10.1021/jf505461x. View

Barone M, Gimigliano A, Castoria G, Paolella G, Maurano F, Paparo F . Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut. 2006; 56(4):480-8. PMC: 1856836. DOI: 10.1136/gut.2005.086637. View

Comino I, Real A, Vivas S, Siglez M, Caminero A, Nistal E . Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr. 2012; 95(3):670-7. PMC: 3278243. DOI: 10.3945/ajcn.111.026708. View

10.

Zimmer K, Fischer I, Mothes T, Weissen-Plenz G, Schmitz M, Wieser H . Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut. 2009; 59(3):300-10. DOI: 10.1136/gut.2008.169656. View

11.

Barone M, Zanzi D, Maglio M, Nanayakkara M, Santagata S, Lania G . Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One. 2011; 6(2):e17039. PMC: 3045409. DOI: 10.1371/journal.pone.0017039. View

12.

Mamone G, Ferranti P, Rossi M, Roepstorff P, Fierro O, Malorni A . Identification of a peptide from alpha-gliadin resistant to digestive enzymes: implications for celiac disease. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 855(2):236-41. DOI: 10.1016/j.jchromb.2007.05.009. View

13.

Reinke Y, Behrendt M, Schmidt S, Zimmer K, Naim H . Impairment of protein trafficking by direct interaction of gliadin peptides with actin. Exp Cell Res. 2011; 317(15):2124-35. DOI: 10.1016/j.yexcr.2011.05.022. View

14.

Barone M, Nanayakkara M, Paolella G, Maglio M, Vitale V, Troiano R . Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One. 2010; 5(8):e12246. PMC: 2923621. DOI: 10.1371/journal.pone.0012246. View

15.

Barone M, Troncone R, Auricchio S . Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa. Int J Mol Sci. 2014; 15(11):20518-37. PMC: 4264181. DOI: 10.3390/ijms151120518. View

16.

Caputo I, Barone M, Lepretti M, Martucciello S, Nista I, Troncone R . Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. Biochim Biophys Acta. 2010; 1802(9):717-27. DOI: 10.1016/j.bbadis.2010.05.010. View

17.

Lubbing N, Barone M, Rudloff S, Troncone R, Auricchio S, Zimmer K . Correction of gliadin transport within enterocytes through celiac disease serum. Pediatr Res. 2011; 70(4):357-62. DOI: 10.1203/PDR.0b013e31822a31e7. View

18.

Schumann M, Richter J, Wedell I, Moos V, Zimmermann-Kordmann M, Schneider T . Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut. 2008; 57(6):747-54. DOI: 10.1136/gut.2007.136366. View

19.

Sturgess R, Ellis H, Ciclitira P . Cereal chemistry, molecular biology, and toxicity in coeliac disease. Gut. 1991; 32(9):1055-60. PMC: 1379050. DOI: 10.1136/gut.32.9.1055. View

20.

Nanayakkara M, Lania G, Maglio M, Discepolo V, Sarno M, Gaito A . An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Am J Clin Nutr. 2013; 98(4):1123-35. DOI: 10.3945/ajcn.112.054544. View